Tema ETFs’s Immunome IMNM Stock Holding History

Tema ETFs’s Portfolio IMNM Stock Details IMNM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$5.07M	Sell	235,688 -32,479	-12%	-$806K	0.19%	109
2026 Q2	$5.68M	Sell	268,167 -7,729	-3%	-$165K	0.18%	100
2026 Q1	$6.03M	Buy	275,896 +173,841	+170%	+$3.87M	0.41%	72
2025 Q4	$2.19M	Sell	102,055 -60,131	-37%	-$1.06M	0.17%	145
2025 Q3	$1.9M	Buy	162,186 +46,755	+41%	+$465K	0.16%	166
2025 Q2	$1.07M	Buy	+115,431	New	+$946K	0.29%	105

Other funds holding IMNM

MWM

Maltin Wealth Management Ridgewood, New Jersey $308M AUM 16.5% 1-Year Est. Return

GWM

GK Wealth Management Reno, Nevada $178M AUM 41.48% 1-Year Est. Return

MLA

MB, Levis & Associates Center Valley, Pennsylvania $273M AUM 8.08% 1-Year Est. Return

GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return

FFO

Fortitude Family Office Scottsdale, Arizona $586M AUM 20.58% 1-Year Est. Return

Versant Capital Management Phoenix, Arizona $1.17B AUM 28.44% 1-Year Est. Return

Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.86B AUM 20.09% 1-Year Est. Return

Tema ETFs's IMNM Position: Q3 2026 in Review

Tema ETFs reduced its Immunome (IMNM) stake by 12% in Q3 2026, selling an estimated $806K and leaving 235,688 shares worth $5.07M. The position accounts for 0.19% of the portfolio, ranked #109.

Tema ETFs first reported a position in IMNM in Q2 2025 and has held it in 6 quarters since. The position peaked at $6.03M in Q1 2026. 9 funds tracked by Wall St. Rank hold IMNM as of Q3 2026.

Tema ETFs held 235,688 shares of Immunome worth $5.07M as of Q3 2026.
Tema ETFs sold 32,479 Immunome shares in Q3 2026, an estimated $806K.
Immunome made up 0.19% of Tema ETFs's portfolio in Q3 2026, its #109 holding.
Tema ETFs first reported a position in Immunome in Q2 2025 and has held it in 6 quarters since.
Tema ETFs's Immunome position peaked at $6.03M in Q1 2026.
9 funds tracked by Wall St. Rank held Immunome as of Q3 2026.

Based on Tema ETFs's 13F filing for Q3 2026, filed 16 Oct 2026.